EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EBS Technologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10917
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. Its Eyetronic Therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. EBS’s Eyetronic Therapy stimulates the metabolism of the neurons in order to restore the function and to stop further cell degeneration. The company’s products are available in selected European markets. EBS is headquartered in Kleinmachnow, Germany.

EBS Technologies GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH – Key Competitors 14
EBS Technologies GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Key Facts 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH, Key Competitors 14

List of Figures
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • Euro Multivision Ltd. (EUROMULTI):企業の財務及び戦略的SWOT分析
    Summary Euro Multivision Ltd. (Euro Multivision) is a solar energy equipment company that provides photovoltaic systems and data storage media. The company’s photovoltaic products include solar cells, solar modules, solar power plants, solar glass, solar aluminum frames, junction boxes, street and g …
  • Ener1, Inc. (formerly Inprimis, Inc.; Boca Research, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ener1, Inc. (formerly Inprimis, …
  • System Capital Management Holdings:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' System Capital Management Holdi …
  • Starwood Energy Group Global, LLC:企業のM&A・提携動向(発電分野)
    Summary Starwood Energy Group Global, LLC (Starwood Energy Group), a subsidiary of Starwood Capital Group is an energy infrastructure investment company that invests in natural gas and renewable power generation, and power transmission sectors. The company offers financing services for the acquisiti …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • InnerWorkings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' InnerWorkings, Inc. Mergers and …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • China Power International Development Ltd (2380):電力:M&Aディール及び事業提携情報
    Summary China Power International Development Ltd (China Power) is a conventional energy business of State Power Investment Corp., carries out generation and sales of electricity. The company invests, develops, constructs, owns, operates and manages power plants in Mainland China. It has interests i …
  • Balfour Beatty plcの企業概要及び財務/SWOT分析
    Balfour Beatty plc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Balfour Beatty plc annual and quarterly forecasts made by stock market experts. The report also enables dir …
  • Jubilant Biosys, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Jubilant Biosys, Ltd. Mergers a …
  • Capita plc:企業のM&A・提携・投資分析
    Capita plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Capita plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • OMV Petrol Ofisi A.S.:企業のM&A・提携動向(石油・ガス分野)
    Summary OMV Petrol Ofisi A.S. (OMV Petrol), formerly Petrol Ofisi A.S., is a fuel products distribution and lubricants company. It is a subsidiary of OMV Petrol Ofisi Holding A.S. OMV Petrol is one of the top three companies in Turkey. It undertakes supply, distribution, storage and marketing of pet …
  • SOHM Inc.(製薬・医療分野):企業M&A動向
    Summary SOHM Inc. (SOHM) is a pharmaceutical company. The company manufactures and markets generic, pharmaceuticals, over the counter, cosmeceuticals and nutraceutical products for healthcare market. Its products include sonim 100, sonim p, sonim bt, sonim suspension, k-gesic, dipagesic, parci, kamp …
  • AeroMaoz Ltd.(航空・防衛):企業概要、SWOT分析
    Summary SDI's "AeroMaoz Ltd.: Aerospace and Defense - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, k …
  • Acea S.p.A:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Acea S.p.A Mergers and Acquisit …
  • Cabela’s Incorporated:戦略・SWOT・企業財務分析
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Isuzu Motors Ltd (7202):企業の財務・戦略的SWOT分析
    Isuzu Motors Ltd (7202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MarketSource, Inc.:企業の戦略的SWOT分析
    MarketSource, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Orca Exploration Group Inc. (ORC.B):企業概要、財務及び戦略的SWOT分析
    Summary Orca Exploration Group Inc. (Orca Exploration) is an oil and gas company. The company explores, develops and markets and supplies natural gas in Tanzania. It has operations in Tanzania and Italy. Orca Exploration operates one licence in Tanzania which includes two discovery blocks. The compa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆